Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00073424 · ClinicalTrials.gov registry record

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
200
Enrollment target
20
Study locations

NCT00073424 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 200 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00073424, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
200 participants
Enrollment target
20
Study locations

Study Summary

Taking anti-HIV medication consistently and properly is a critical issue for patients with HIV. Drug regimens are complex; when regimens are not taken properly, HIV can become resistant to the drugs. Taking anti-HIV medication properly leads to improved health. Children and adolescents with HIV face unique challenges to taking HIV medication properly. This study will look at the relationship between how children cope with the responsibility for taking medication and the child's language, memory, attention, behavior, and academic skills. This study is open to children and adolescents who are currently enrolled in the PACTG 219C study (Long-Term Effects of HIV Exposure and Infection in Children).

Conditions Studied

HIV Infections

Study Locations (20)

California

  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. - Long Beach
  • Usc La Nichd Crs - Los Angeles
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. - Oakland
  • UCSD Mother-Child-Adolescent Program CRS - San Diego
  • UCSF Pediatric AIDS CRS - San Francisco

District of Columbia

  • Children's National Med. Ctr., ACTU - Washington D.C.
  • Howard Univ. Washington DC NICHD CRS - Washington D.C.

Florida

  • South Florida CDTC Ft Lauderdale NICHD CRS - Fort Lauderdale
  • Univ. of Miami Ped. Perinatal HIV/AIDS CRS - Miami

Maryland

  • Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology - Baltimore
  • Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases - Baltimore

Massachusetts

  • HMS - Children's Hosp. Boston, Div. of Infectious Diseases - Boston
  • Baystate Medical Center, Springfield - Springfield

Alabama

  • UAB, Dept. of Ped., Div. of Infectious Diseases - Birmingham

Arizona

  • Phoenix Children's Hosp. - Phoenix

Colorado

  • Univ. of Colorado Denver NICHD CRS - Denver

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2004-01
Est. Completion 2006-10

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00073424

The ClinicalTrials.gov registry entry for NCT00073424 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00073424 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT00073424 about?

NCT00073424 is a clinical study titled "Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents". Taking anti-HIV medication consistently and properly is a critical issue for patients with HIV. Drug regimens are complex; when regimens are not taken properly, HIV can become resistant to the drugs. Taking anti-HIV medication properly leads to improved health. Children and adolescents with HIV face...

What is the current status of trial NCT00073424?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2004-01. Estimated completion is 2006-10.

What conditions does trial NCT00073424 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00073424?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00073424 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.